Annual EBITDA
-$741.79M$365.63M-97.20%
Summary
- Current Value
- As of today, RNA annual EBITDA is -$741.79M, down -97.20% on
- Historical Performance
- RNA annual EBITDA is down -317.85% over the past 3 years, down -1589.58% over the past 5 years
- All-Time High Comparison
- RNA annual EBITDA is currently -7233.58% below its historical high of -$10.12M set on
- 3-Year Low Comparison
- RNA annual EBITDA is at its 3-year low
- Sector Comparison
- RNA annual EBITDA is higher than 0.71% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$741.79M | -97.2% | -317.9% | -1589.6% | -7233.6% | |
| Quarterly EBITDA | -$22.28M | -74.2% | +56.6% | +15.1% | -1002.7% | |
| TTM EBITDA | -$68.38M | +44.8% | +66.7% | +11.8% | -3285.3% | |
| Price | $13.20 | – | – | – | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $18.62M | +70.8% | +101.8% | +174.3% | +4812.4% | |
| Annual EPS | -$2.89 | -97.0% | +13.3% | -41.3% | -867.4% | |
| -$745.94M | -96.8% | -316.9% | -1584.7% | -7005.6% | ||
| Annual Net Income | -$49.50M | -97.0% | +71.5% | -11.6% | -341.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$177.53M | N/A | -317.9% |
| 5Y | -$43.90M | N/A | -1589.6% |
| All | -$10.12M | -7233.6% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$741.79M | at low | |
| 5Y | -$741.79M | at low | |
| All | -$741.79M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$741.79M | -97.2% | |
| -$376.16M | -61.1% | |
| -$233.50M | -31.5% | |
| -$177.53M | -51.2% |
| Year | Value | Change |
|---|---|---|
| -$117.41M | -167.4% | |
| -$43.90M | -162.3% | |
| -$16.74M | -65.4% | |
| -$10.12M | - |
FAQ
- What is the current annual EBITDA of RNA?
- As of today, RNA annual EBITDA is -$741.79M
- What is 1-year change in RNA annual EBITDA?
- RNA annual EBITDA is down -97.20% year-over-year
- What is 3-year change in RNA annual EBITDA?
- RNA annual EBITDA is down -317.85% over the past 3 years
- How far is RNA annual EBITDA from its all-time high?
- RNA annual EBITDA is currently -7233.58% below its historical high of -$10.12M set on December 31, 2018
- How does RNA annual EBITDA rank versus sector peers?
- RNA annual EBITDA is higher than 0.71% of companies in Healthcare sector
- When is RNA next annual earnings release?
- As of today, the next annual earnings release for RNA has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
-$22.28M$5.15M-30.04%
Summary
- Current Value
- As of today, RNA quarterly EBITDA is -$22.28M, down -30.04% on
- Historical Performance
- RNA quarterly EBITDA is down -74.23% year-over-year, up +56.64% over the past 3 years
- All-Time High Comparison
- RNA quarterly EBITDA is currently -1002.72% below its historical high of -$2.02M set on
- 3-Year Low Comparison
- RNA quarterly EBITDA is +77.14% above its 3-year low of -$97.42M reached on
- Sector Comparison
- RNA quarterly EBITDA is higher than 20.80% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$22.28M | -30.0% | -74.2% | +56.6% | +15.1% | |
| Annual EBITDA | -$741.79M | – | -97.2% | -317.9% | -1589.6% | |
| TTM EBITDA | -$68.38M | -16.1% | +44.8% | +66.7% | +11.8% | |
| Price | $13.20 | +1.2% | – | – | – | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $3.00M | -84.7% | -21.9% | +29.7% | +15.2% | |
| Quarterly EPS | -$1.18 | -21.4% | -56.7% | -79.1% | -68.3% | |
| -$22.62M | -30.9% | -75.8% | +57.0% | +14.2% | ||
| Quarterly Net Income | -$20.19M | -21.4% | -56.7% | +57.1% | +23.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$12.79M | N/A | -74.2% |
| 3Y | -$6.19M | -259.7% | |
| 5Y | -$6.19M | -259.7% | |
| All | -$2.02M | -1002.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$28.98M | +23.1% | |
| 3Y | -$97.42M | +77.1% | |
| 5Y | -$97.42M | +77.1% | |
| All | -$97.42M | +77.1% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of RNA?
- As of today, RNA quarterly EBITDA is -$22.28M
- What is RNA quarterly EBITDA most recent change?
- RNA quarterly EBITDA was down -30.04% on June 1, 2026
- What is 1-year change in RNA quarterly EBITDA?
- RNA quarterly EBITDA is down -74.23% year-over-year
- How far is RNA quarterly EBITDA from its all-time high?
- RNA quarterly EBITDA is currently -1002.72% below its historical high of -$2.02M set on March 31, 2019
- How does RNA quarterly EBITDA rank versus sector peers?
- RNA quarterly EBITDA is higher than 20.80% of companies in Healthcare sector
- When is RNA next earnings release?
- As of today, the next earnings release for RNA has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
-$68.38M$9.49M-16.11%
Summary
- Current Value
- As of today, RNA TTM EBITDA is -$68.38M, down -16.11% on
- Historical Performance
- RNA TTM EBITDA is up +44.76% year-over-year, up +66.68% over the past 3 years
- All-Time High Comparison
- RNA TTM EBITDA is currently -3285.35% below its historical high of -$2.02M set on
- 3-Year Low Comparison
- RNA TTM EBITDA is +78.77% above its 3-year low of -$322.04M reached on
- Sector Comparison
- RNA TTM EBITDA is higher than 23.46% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$68.38M | -16.1% | +44.8% | +66.7% | +11.8% | |
| Annual EBITDA | -$741.79M | – | -97.2% | -317.9% | -1589.6% | |
| Quarterly EBITDA | -$22.28M | -30.0% | -74.2% | +56.6% | +15.1% | |
| Price | $13.20 | +1.2% | – | – | – | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $23.50M | -3.5% | +119.0% | +139.8% | +155.4% | |
| TTM EPS | -$3.85 | -12.5% | -53.4% | -24.1% | -85.6% | |
| -$69.00M | -16.5% | +44.7% | +66.9% | +11.5% | ||
| TTM Net Income | -$65.96M | -12.5% | +41.2% | +65.9% | +15.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$49.16M | -39.1% | |
| 3Y | -$49.16M | -39.1% | |
| 5Y | -$49.16M | -39.1% | |
| All | -$2.02M | -3285.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$123.80M | N/A | +44.8% |
| 3Y | -$322.04M | +78.8% | |
| 5Y | -$322.04M | +78.8% | |
| All | -$322.04M | +78.8% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of RNA?
- As of today, RNA TTM EBITDA is -$68.38M
- What is RNA TTM EBITDA most recent change?
- RNA TTM EBITDA was down -16.11% on June 1, 2026
- What is 1-year change in RNA TTM EBITDA?
- RNA TTM EBITDA is up +44.76% year-over-year
- How far is RNA TTM EBITDA from its all-time high?
- RNA TTM EBITDA is currently -3285.35% below its historical high of -$2.02M set on March 31, 2019
- How does RNA TTM EBITDA rank versus sector peers?
- RNA TTM EBITDA is higher than 23.46% of companies in Healthcare sector
- When is RNA next earnings release?
- As of today, the next earnings release for RNA has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- RNA Official Website www.atriumtherapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1599901/000159990126000031/0001599901-26-000031-index.htm
- RNA Profile on Yahoo Finance finance.yahoo.com/quote/RNA
- RNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rna